Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
Posted inAcademic and Scientific Journals Alzheimer's Disease Cassava Sciences Inc City University of New York Clinical Trials Dementia Drugs (Pharmaceuticals) Falsification of Data Food and Drug Administration Regulation and Deregulation of Industry Securities and Commodities Violations Securities and Exchange Commission United States Wang, Hoau-Yan your-feed-science

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug
Posted inAcademic and Scientific Journals Alzheimer's Disease Appointments and Executive Changes Cassava Sciences Inc City College of New York Clinical Trials Drugs (Pharmaceuticals) Falsification of Data Research Securities and Commodities Violations your-feed-science

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.